期刊文献+

视黄酸调节IL-1β和IFN-γ诱导肺癌细胞分泌C3及B因子的实验研究 被引量:1

Experimental study of effects of retinoic acid on IL-1β and IFN-γ induced C3 and factor B secretion in lung cancer cell line
下载PDF
导出
摘要 背景与目的肺癌的发病率急剧上升,寻找有效的防治方法是迫切需要的。本研究旨在从免疫治疗的角度探讨近年来用于治疗恶性肿瘤的视黄酸(RA)与IL1β和IFNγ间的相互作用对人肺癌细胞株A549分泌C3及B因子(Bf)的影响。方法用ELISA、Westernblot的方法检测肺癌细胞株培养液中C3及Bf蛋白,用RTPCR法检测细胞核内C3及Bf的mRNA。结果ELISA、Westernblot和RTPCR法均显示IL1β和IFNγ促进A549细胞中C3和Bf的分泌及其mRNA的表达。视黄酸对A549细胞分泌C3及Bf没有影响,但它能进一步增强IL1β诱导的A549中C3、BfmRNA的表达和C3、Bf的分泌,以及IFNγ诱导的A549细胞中BfmRNA的表达和Bf的分泌。结论视黄酸可上调IL1β及IFNγ诱导人肺癌细胞株A549分泌C3及Bf,稳定补体系统激活因子与抑制因子间的平衡,对杀伤肿瘤细胞起到一定的作用,为临床上共同应用视黄酸与细胞因子治疗肺癌提供了理论依据。 Background and objective It is urgently necessary to research an effective method to prevent and treat lung cancer since its incidence has increased sharply. The aim of this study is to investigate the regulated effects of retinoic acid (RA) on IL-1β and IFN-γ induced C3 and factor B secretion in human lung cancer cell line A549. Methods C3 and factor B in cultured medium were measured in lung cancer cell line A549 by ELISA and Western blot, and their cellular mRNA levels were measured by RT-PCR analysis. Results ELISA, Western blot and RT-PCR results showed that IL-1β and IFN-γ could significantly increase C3 and factor B secretion and their mRNA levels in A549 cells. RA alone did not affect C3 and factor B level in A549 cells, but it could potentiated C3 and factor B secretion and their mRNA expression induced by IL-1β, as well as factor B secretion and its mRNA expression induced by IFN-γ. Conclusion RA can up-regulate C3 and factor B secretion induced by IL-1β and IFN-γ in human lung cancer cell A549. It may stabilize the balance between stimulator cytokines and inhibitor cytokines in complement system, and play a certain role in killing tumor cells. The results suggest that combination of RA and cytokines might be effective in the treatment of lung cancer.
出处 《中国肺癌杂志》 CAS 2005年第3期170-174,共5页 Chinese Journal of Lung Cancer
基金 辽宁省博士启动基金(No.2001102048)资助
关键词 视黄酸 补体 肺肿瘤 Retinoic acid Complement Lung neoplasms
  • 相关文献

参考文献13

  • 1Andoh A, Fujiyama Y, Bamba T, et al. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco 2. J Immunol, 1993,151 (8):4239 4247.
  • 2de Bruijn MH, Fey GH. Human complement component C3:cDNA coding sequence and derived primary structure. Proc Natl Acad Sci U S A,1985,82(3): 708-712.
  • 3Horiuchi T, Kim S, Matsumoto M, et al. Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression. Mol Immunol,1993,30(17) : 1587-1592.
  • 4Walport MJ. Complement. Second of two parts. N Engl J Med,2001,344(15) : 1140-1144.
  • 5Jurianz K, Ziegler S, Garcia-Schuler H, et al. Complement resistance of tumor cells: basal and induced mechanisms. Mol Immunol,1999,36(13 14) : 929 939.
  • 6Jason J, Archibald LK, Nwanyanwu OC, et al. Vitamin A levels and immunity in humans. Clin Diagn Lab Immunol,2002,9(3) :616 621.
  • 7Munoz Canoves P, Vik DP, Tack BF. Mapping of a retinoic acid responsive element in the promoter region of the complement factor H gene. J Biol Chem,1990,265(33) : 20065 20068.
  • 8Funkhouser TA, Vik DP. Complement receptor type 1 gene regu lation: retinoic acid and cytosine arabinoside increase CR1 expres sion. ScandJ Immunol,1999,49(1) : 21 28.
  • 9Scantlebury T, Sniderman AD, Cianflone K. Regulation by retinoic acid of acylation stimulating protein and complement C3 in hu man adipocytes. Biochem J,2001,356(Pt 2) : 445-452.
  • 10Zhao YX, Andoh A, Shimada M, et al. Secretion of complement components of the alternative pathway (C3 and factor B) by the human alveolar type Ⅱ epithelial cell line A549. Int J Mol Med,2000,5(4) : 415-419.

同被引文献7

  • 1梅江华,王明伟.选择性RXR配体的研究进展[J].药学学报,2005,40(4):294-298. 被引量:3
  • 2吴楠,张文,梁玉龙,靳嘉巍,王丽影,蔡秀梅,查锡良.全反式视黄酸可上调人肝癌细胞中低表达的profilin 1[J].复旦学报(医学版),2006,33(2):171-174. 被引量:2
  • 3Yen WC, Prudente RY, Lamph WW. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (raxol) in mammary carcinoma [J]. Breast Cancer Res Treat, 2004,88:141- 148.
  • 4Yen WC, Manny R, Corpuz MR, et al. A selective retinoid X reeep tot agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non small-cell Lung cancer (NSCLC)[J]. Clin Cancer Res. 2004. 10: 8656-8664.
  • 5JB Patel, J Mehta, A Belosay, et al.Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth[J].Br J Cancer, 2007,96: 1204-1215.
  • 6Tae Kyong Hong, Yang Cha Lee-Kim. Effects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cells[J]. Nutr Res Pract, 2009,3: 77-83.
  • 7和付林,王力,张晓坤,曾锦章.大黄素诱导癌细胞凋亡和抑制视黄醇X受体的转录激活功能[J].药学学报,2008,43(4):350-355. 被引量:13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部